Shionogi has concluded an exclusive global licence agreement for Maze Therapeuti...
Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmi...
GlobalData examines four of the key trends affecting contract research organizat...
Attovia Therapeutics has secured $105m in a Series B financing round to expedite...
Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biot...
Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise ...
RAPT is closing two Phase II trials for Rapt’s lead candidate, zelnecirnon, thre...
The positive Phase I/II data has supported a RMAT designation from the FDA and a...
The FDA has given an IND approval for WestGene’s mRNA therapeutic cancer vaccine...
Discover key insights into the selection of oral solid dosage manufacturing comp...
The US FDA has granted fast track designation for iECURE’s ECUR-506 for the trea...
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, c...
We look at the top six most important trends in pharmaceutical milling and how t...
BioVersys and GSK have announced the expansion of their partnership to expedite ...
TerSera has obtained Health Canada approval for ZOLADEX LA 10.8mg to manage oest...
The companies will utilise Broken String’s DNA break mapping platform Induce-seq...
